(S)-1-Boc-3-hydroxyperpipiidine CAS NO 143900-44-1

Pwodwi Deskripsyon:

Non pwodwi: (S) -1-Boc-3-hydroxyperidine CAS NON: 143900-44-1

 

Sinonim:

(S)-1-Tert-Butoxycarbonyl-3-Hydroxyperpiidine;

(S)-3-Hydroxy-Piperidine-1-Carboxylicacidter-Butylester;

(S)-3-Hydroxy-1-(Tert-Butoxycarbonyl)Piperidine;

(S)-1-Boc-3-Piperidinol;

(S) -N-(Tert-Butoxycarbonyl) -3-Hydroxyperidinehydrochloride;

(S)-N-Boc-3-Hydroxyperpiidine;

(S)-Tertbutyl-3-Hydroxyperidine-1-Carboxylate;

(S) -1-(tert-Butoxycarbonyl) -3-hydroxypperidine;

 

Chimik & Pwopriyete fizik:

Aparans : Blan pou Pale Jon poud.

Assay: ≥99.0%

Dansite: 1.107g / cm³

Fonn pwen: 34-40 ° C

Bouyi pwen: 292.3 ° C nan 760 mmHg

Flash Pwen: 110 ° C

Endeks refraktif: 1.495

Vapore Presyon: 0.0mmHg nan 25 ° C

PSA: 49.77000

LogP: 1.31610

Pka: 14.74±0.30 (Prediksyon)

Solibilite: Soluble nan metanol.

Kategori: Piperidines; Piperazine; Pharmaceutiical / API Dwog Entemedye;

 

 

Enfomasyon sekirite:

HS Kod: 2933990900

Deklarasyon Sekirite: S26

Deklarasyon Risk: R36 /37/38

Kod danje: Xi

 

Depo:Estoke nan yon veso fre ak sek ki byen femen. Kenbe lwen imidite ak limye fo / chale.

 

Aplikasyon:

1,1-dimethylethyl (3S) -3-hydroxyperidine-1-kaboksilate se yon entemedye chiral enpotan pou sentez la nan ibrutinib, yon anticancer dwog vize malignik B-selil. Sentez nan entemedye famasetik ki gen ladan ibrutinib, API a nan Imbruvica nan ki fek apwouve Imbruvica, pou tretman an nan lenfom.

 

faktori nou an (3S) -1-(tert-Butyloxycarbonyl)piperidine-3-ol, teknoloji matirite, pwodiksyon ki estab, asirans kalite.

Estati envante: nan stock.

 

Nou ka bay (S)-3-hydroxy-N-Boc-piperidine COA (setifika analiz), (S) -1-BOC-PIperidin-3-ol MOA (Metod nan analiz), (3S) -1-(tert-Butoxycarbonyl) -3-hydroxypiperidine ROS (Wout nan sentez), (S) -N-tert-Butoxycarbonyl-3-hydroxyperpiidine MSDS (Materyel Sekirite Done Fey) ak lot sipo pou ou!

 

 nou ka pwouve Ibrutinib ak Entemedye:

Ibrutinib ak Entemedye	BOUCH PA GEN OKENN
Ibrutinib	936563-96-1
1-Piperidinecarboxylicacid,3-[4-amino-3-(4-phenoxyphenyl) -1H-pirazolo[3,4-d]pirimidin-1-yl]-,1,1-dimethylethylester,(3R)-	1022150-11-3
(S)-1-Boc-3-hydroxyperpiidine	143900-44-1
3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pirimidin-4-ylamine	1022150-12-4
5-(4-phenoxyphenyl) -7H-pirrolo [2,3-d]pirimidin-4-ylamine	330786-24-8
5-amino-3-(4-phenoxyphenyl) -1H-pyrazole-4-kabonitrile	330792-70-6
(R) -3-(4-phenoxyphenyl) -1-(piperidin-3-yl) -1H-pirazolo[3,4-d]pirimidin-4-aminedihydrochoride	1701403-10-2
4-Amino-3-iodo-1H-prayzolo[3,4-d]pirimidin	151266-23-8
4-Phenoxyphyenyl asd de boronic	51067-38-0

 

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

Baj popilè: (s)-1-boc-3-hydroxypiperidine cas pa 143900-44-1, manifaktire, founise, faktori, achte, nan stock

• On: 3- (4-Phenoxy-phenyl) -1-piperidin-3-yl-1H-pyrazolo [3,4-d] pirimidin-4-ylamine CAS NON 1022150-12-4
• Pwochen: 1-Piperidinecarboxylicacid, 3- [4-amino-3- (4-phenoxyphenyl) -1H-pyrazolo [3,4-d] pirimidin-1-il] -, 1,1-dimethylethylester, (3R) - CAS NON 1022150 -11-3